How should we be defining a meaningful clinical response to TNF-blockers in ankylosing spondylitis patients?

M Stone, D Cortinovis, A G Raj, A Maetzel, R Inman, V Lapp, D Beaton

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)544-544
Number of pages1
JournalAnnals of the Rheumatic Diseases
Volume65
Publication statusPublished - 2006

Cite this

Stone, M., Cortinovis, D., Raj, A. G., Maetzel, A., Inman, R., Lapp, V., & Beaton, D. (2006). How should we be defining a meaningful clinical response to TNF-blockers in ankylosing spondylitis patients? Annals of the Rheumatic Diseases, 65, 544-544.